Give your opinion on a genetically modified vaccine to treat colorectal cancer
November 4, 2021
The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified vaccine VSV-GP128 to treat colorectal cancer. The public consultation will run from 1 November 2021 to 1 December 2021.
For each clinical trial application related to the use of genetically modified organisms, the authority organises a thirty-day public consultation, in accordance with the Royal Decree of 21 February 2005(link is external). As a citizen, you can share your opinion on the clinical trial application for the genetically modified vaccine VSV-GP128.